Need PowerPoint Inspiration? SlideShare's Top 5 Fun Presentation Ideas | PGi Blog We all love to hate a horrendous presentation, but SlideShare’s amazingly talented crowd has some amazingly fun presentation ideas that will help you be the best in your company. Here are the top 5 SlideShare presentations with fun presentation ideas you can use today. 1. Death by PowerPoint (and how to fight it) — Alexei Kapterev The stats in this presentation are awe-inspiring, with an estimated 300 million PowerPoint users worldwide giving an average of 30 million presentations each day. 2. This author’s personal favorite “presentation about presentations,” Mr. 3. PGi’s own fun presentation ideas guide is a presentations sneak peek from its powerful eBook of the same name. 4. Mr. 5. Slide Comet’s presentation takes the world’s best presenters and boils down their techniques into slide design tips you can use. What are your favorite presentations about presentations on SlideShare?
Top 5 pharma marketing trends in 2014 - Pharma Marketing - K-Message Approaching end of the year experts have two options to choose. The first and a safer one is to summarize past twelve months. The second, more dangerous but also more exciting is to predict what will happen next year. At K-message we find the latter option much more useful and interesting. Please enjoy our prediction of the Top 5 pharma marketing trends of 2014 below. Top 5 pharma marketing trends for 2014 1. CLM – Closed Loop Marketing For years digital marketing was treated as a fifth wheel in pharma business. However, during past few years this traditional sales force thinking was challenged. Digital came to help with e-detailing and web-based self-detail solutions. This Multi Channel Marketing approach allows even better results with something Pharma marketers call Closed Loop Marketing (CLM). Those data combined may be used to shape the content of personalized newsletter send to the doctor X as the follow-up for the visit. The concept is easy to describe, but very hard to achieve.
L'impression 3D révolutionne la médecine ? On fait le point En ce mois de janvier 2014, l’impression 3D n’en est qu’encore qu’au temps des espoirs et des promesses. Additiverse vous propose un point sur les projets existants et évolutions médicales qui risquent de changer la médecine moderne, du diagnostique au traitement. Ici, nous n’essaierons pas de répondre aux questions d’éthiques, théologiques, philosophiques inhérentes aux avancées médicales. Nous vous proposons juste de faire un arrêt sur image l’impression 3D médicale en ce début 2014. Le monde de l’impression 3D est tellement riche en déclarations qui relèvent de la science-fiction, que pour beaucoup d’entre nous c’est l’incrédulité qui prend le pas et laisse place à St Thomas et son fameux dicton. L’impression 3D au secours d’un bébé : En octobre 2011, Kaiba Gionfriddo, né en bonne santé dans la ville de Youngstown dans l’état de l’Ohio. En 2011, Anthony Atala, chirurgien présente son projet de pallier au manque d'organe par l'impression d'un rein : Janvier 2014, Fayz Y.
Digital Handbook To help make this website better we have placed cookies on your computer. You can change your cookie settings at any time. Otherwise, we'll assume you're OK to continue. REMOVE THIS MESSAGE PMGroup Please login to the form below Not currently logged in I have forgotten my password Pharma social media directory Mobile pharma apps Facebook 'considering' new online health communities and apps Social network is reportedly exploring healthcare options Medical device firms told to address cybersecurity risks FDA says online security should be part of a device's design and development Doctors.net.uk expands its online educational resources for doctors Includes video for three procedures that all doctors are expected to be able to do Review: diabetes tweetchat Some of the key points from the recent #M3diabetes tweetchat held by PMLiVE and M3 Europe Boehringer Ingelheim launches Sound Challenge app Looks to raise awareness of rare lung disease IPF Pharma and digital Dealing with digitally native HCPs Social media
Pharma's digital directions in 2014 For all the chatter that's been heard over the years about how pharmaceutical companies just don't 'get' digital marketing, one of the most striking results from our recent Digital Futures 2014 survey was how well-aligned company and individual priorities seem to be. The online survey, run by PMLiVE publisher PMGroup in association with Havas Lynx, heard the views of nearly 250 people working in and for the pharma industry. Among the questions were those that asked what aspects of digital marketing individuals would like to make more use of in 2014 and which ones they thought their company would focus on over the next 12 months. Before analysing the responses I had expected to find individuals chomping at the bit to launch 'gamification' or 'quantified self' initiatives, along the lines of the sometimes innovative (but sometimes just buzzword-friendly) work that features in the Digital Intelligence blog. Digital Futures 2014 survey • See also: J&J expected to make best use of digital in 2014
About the Center for Drug Evaluation and Research > Social Media Guidance Webinar – July 10, 2014 The Social Media Draft Guidance Webinar held on July 10, 2014, experienced connection issues. We recognize the considerable interest in this subject, and we apologize that due to technical difficulties, many registrants were not able to access the webinar. The slides from the webinar are available at the link below. Technology is continually changing, but FDA’s commitment to public health does not. OPDP, in the Center for Drug Evaluation and Research (CDER) consulted with other FDA Centers, including the Center for Biologics Evaluation and Research (CBER), the Center for Veterinary Medicine (CVM), and the Center for Devices and Radiological Health (CDRH). To further our communications with stakeholders, media and the public in this area, FDA will host a webinar and Q&A session on July 10, 2014, from 2:00-3:00 p.m. We will present an introduction and overview of FDA’s three most-recently issued social media draft guidances: